6771 related articles for article (PubMed ID: 21141087)
1. Diagnosis and treatment protocols of cutaneous melanoma: latest approach 2010.
Petrescu I; Condrea C; Alexandru A; Dumitrescu D; Simion G; Severin E; Albu C; Albu D
Chirurgia (Bucur); 2010; 105(5):637-43. PubMed ID: 21141087
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathological Features, Staging, and Current Approaches to Treatment in High-Risk Resectable Melanoma.
Keung EZ; Gershenwald JE
J Natl Cancer Inst; 2020 Sep; 112(9):875-885. PubMed ID: 32061122
[TBL] [Abstract][Full Text] [Related]
3. SEOM guidelines for the management of Malignant Melanoma 2015.
Berrocal A; Arance A; Espinosa E; Castaño AG; Cao MG; Larriba JL; Martín JA; Márquez I; Soria A; Algarra SM
Clin Transl Oncol; 2015 Dec; 17(12):1030-5. PubMed ID: 26669314
[TBL] [Abstract][Full Text] [Related]
4. Clinical practice consensus for the diagnosis and management of melanoma in Taiwan.
Wu CE; Liao YH; Wu CL; Yen RF; Lin CC; Yang MH; Yen CC; Su WC; Yen CJ; Chang YF; Wu MF; Yang Y; Lin CY; Yang WC; Wang HC; Li CY; Ho YY; Chang YY; Wu CS; Hsu HC; Chen KH; Huang Y; Chen CJ; Chuang PJ; Lai YC; Huang YY; Tseng NC; Huang YT; Chu CY; Wen-Cheng Chang J
J Formos Med Assoc; 2024 Jan; 123(1):7-15. PubMed ID: 37690868
[TBL] [Abstract][Full Text] [Related]
5. Future perspectives in melanoma research. Meeting report from the "Melanoma Bridge. Napoli, December 2nd-4th 2012".
Ascierto PA; Grimaldi AM; Acquavella N; Borgognoni L; Calabrò L; Cascinelli N; Cesano A; Del Vecchio M; Eggermont AM; Faries M; Ferrone S; Fox BA; Gajewski TF; Galon J; Gnjatic S; Gogas H; Kashani-Sabet M; Kaufman HL; Larkin J; Lo RS; Mantovani A; Margolin K; Melief C; McArthur G; Palmieri G; Puzanov I; Ribas A; Seliger B; Sosman J; Suenaert P; Tarhini AA; Trinchieri G; Vidal-Vanaclocha F; Wang E; Ciliberto G; Mozzillo N; Marincola FM; Thurin M
J Transl Med; 2013 Jun; 11():137. PubMed ID: 23731854
[TBL] [Abstract][Full Text] [Related]
6. Treatment of melanoma.
Garbe C; Terheyden P; Keilholz U; Kölbl O; Hauschild A
Dtsch Arztebl Int; 2008 Dec; 105(49):845-51. PubMed ID: 19561811
[TBL] [Abstract][Full Text] [Related]
7. Analyzing Controversies in Management and Surveillance of Early-Stage Melanoma.
Marushchak O; Hazan E; Kriegel DA
Oncol Ther; 2020 Dec; 8(2):191-196. PubMed ID: 32930972
[TBL] [Abstract][Full Text] [Related]
8. Surgical prevention and treatment of lymphedema after lymph node dissection in patients with cutaneous melanoma.
Boccardo F; De Cian F; Campisi CC; Molinari L; Spinaci S; Dessalvi S; Talamo G; Campisi C; Villa G; Bellini C; Parodi A; Santi PL; Campisi C
Lymphology; 2013 Mar; 46(1):20-6. PubMed ID: 23930438
[TBL] [Abstract][Full Text] [Related]
9. The treatment of melanoma at Westminster Hospital in the 20th century.
Retsas S
J BUON; 2013; 18(2):537-43. PubMed ID: 23818375
[TBL] [Abstract][Full Text] [Related]
10. Expression of the anti-metastatic effect induced by Juzen-taiho-to is based on the content of Shimotsu-to constituents.
Onishi Y; Yamaura T; Tauchi K; Sakamoto T; Tsukada K; Nunome S; Komatsu Y; Saiki I
Biol Pharm Bull; 1998 Jul; 21(7):761-5. PubMed ID: 9703264
[TBL] [Abstract][Full Text] [Related]
11. Isolation and expansion of lymphocytes from gastrointestinal tumour tissue.
Somers SS; Guillou PJ
Surg Oncol; 1993 Oct; 2(5):283-91. PubMed ID: 8305970
[TBL] [Abstract][Full Text] [Related]
12. Intra-arterial hepatic carboplatin-based chemotherapy for ocular melanoma metastatic to the liver. Report of a phase II study.
Cantore M; Fiorentini G; Aitini E; Davitti B; Cavazzini G; Rabbi C; Lusenti A; Bertani M; Morandi C; Benedini V
Tumori; 1994 Feb; 80(1):37-9. PubMed ID: 8191596
[TBL] [Abstract][Full Text] [Related]
13. Amino acid alcohols: growth inhibition and induction of differentiated features in melanoma cells.
Landau O; Wasserman L; Deutsch AA; Reiss R; Panet H; Novogrodsky A; Nordenberg J
Cancer Lett; 1993 May; 69(3):203-8. PubMed ID: 8099846
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, structural characterization, and antitumor properties of a novel class of large-ring platinum(II) chelate complexes incorporating the cis-1,4-diaminocyclohexane ligand in a unique locked boat conformation.
Hoeschele JD; Showalter HD; Kraker AJ; Elliott WL; Roberts BJ; Kampf JW
J Med Chem; 1994 Aug; 37(17):2630-6. PubMed ID: 8064793
[TBL] [Abstract][Full Text] [Related]
15. Phase I trial of cisplatin, WR-2721, and the murine monoclonal antibody R24 in patients with metastatic melanoma: clinical and biologic effects.
Bukowski RM; Murthy SA; Finke J; Caulfield MJ; Tubbs R; Herzog P; Stanley J; Edinger M; Tuason L; McLain D
J Immunother Emphasis Tumor Immunol; 1994 May; 15(4):273-82. PubMed ID: 8061900
[TBL] [Abstract][Full Text] [Related]
16. Ultraviolet-induced p53 mutations in atypical fibroxanthoma.
Dei Tos AP; Maestro R; Doglioni C; Gasparotto D; Boiocchi M; Laurino L; Fletcher CD
Am J Pathol; 1994 Jul; 145(1):11-7. PubMed ID: 8030743
[TBL] [Abstract][Full Text] [Related]
17. Protein kinases in normal and transformed melanocytes.
Quong RY; Bickford ST; Ing YL; Terman B; Herlyn M; Lassam NJ
Melanoma Res; 1994 Oct; 4(5):313-9. PubMed ID: 7858416
[TBL] [Abstract][Full Text] [Related]
18. Diagnosis of lymphoma, leukemia, and metastatic tumor involvement of the cerebrospinal fluid by cytology and immunocytochemistry.
Tani E; Costa I; Svedmyr E; Skoog L
Diagn Cytopathol; 1995 Feb; 12(1):14-22. PubMed ID: 7789240
[TBL] [Abstract][Full Text] [Related]
19. A comparison of the properties of different retroviral vectors containing the murine tyrosinase promoter to achieve transcriptionally targeted expression of the HSVtk or IL-2 genes.
Vile R; Miller N; Chernajovsky Y; Hart I
Gene Ther; 1994 Sep; 1(5):307-16. PubMed ID: 7584096
[TBL] [Abstract][Full Text] [Related]
20. Immunological aspects of cryosurgery in general surgery.
Tanaka S
Prog Clin Biol Res; 1982; 107():799-814. PubMed ID: 6891963
[No Abstract] [Full Text] [Related]
[Next] [New Search]
